Multinationals abuse Korea's patent trial system

Published: 2008-04-04 06:58:00

Updated: 2008-04-04 06:58:00

Pfizer Korea and Sanofi-Aventis Korea have sought to prevent the insurance prices of their original medicine from being decreased by 20 percent, when a generic drug gets listed for insurance coverage, through a trial to confirm the scope of patent rights over generic products, indicating they are...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK